Emergence client, Delivra Corp’s LivRelief products to be distributed across Canada in single dose size

January 24, 2017

Burlington, Ontario- and Charlottetown, PEI-based Emergence client, Delivra, has announced a new distribution agreement with Spike Marks Inc. (“Spike”) for the launch of its three Over-the-Counter products in a simple and revolutionary single dose travel size.

delivra1As a result of this agreement, consumers will see new 1.5g single-use sachets of the LivRelief Pain Relief Cream, LivRelief Nerve Pain Cream and LivRelief Healing Cream available in convenience stores throughout Canada.


Dr. Joe Gabriel, CEO, Delivra

“Spike offers unparalleled access to the Canadian market, providing comprehensive and consistently outstanding service to more than 27,000 points of sale from Vancouver Island to Newfoundland. This expanded availability and distribution, give consumers a new way to sample our products,” Dr. Joseph Gabriele, Delivra’s Chief Executive Officer, told us.

“In addition, this revolutionary packaging system will be used for Delivra’s future pharmaceutical products to prevent overdosing. Delivra aims to increase brand awareness and drive sales of its larger sized products currently available in pharmacies and retail chains across the country.”

Delivra’s suite of topical creams under the “LivRelief” brand has been available in retail stores since 2012.

The new, convenient single-use packages will begin to make their way into point of purchase displays. The 25-pack displays will make their way into as many as 500 retail locations in Canada, beginning February, 2017. Their patented Easysnap packaging provides hygienic, clean ease of use for added convenience.

Delivra’s suite of products utilizes the transdermal delivery technology developed by Dr. Joseph Gabriele and his team at Delivra.

Delivra uses the innovative transdermal delivery system to deliver target relief using natural ingredients. LivRelief products provide targeted opioid-free pain relief alternatives to millions of Canadians.


Delivra Corp. is a specialty biotechnology company that has a proprietary transdermal delivery system platform that can shuttle pharmaceutical and natural molecules, through the skin, in a targeted specific manner. Delivra manufactures and sells a growing line of natural topical creams with the proprietary transdermal delivery system platform under the LivReliefTM brand, for conditions such as joint and muscle pain, nerve pain, varicose veins, wound healing, and under the LivSportTM brand for sports performance. Further information on Delivra can be found at www.delivracorp.com, www.livrelief.com.